中文名:Glu-Ureido型特异性膜抗原PSMA抑制剂
英文名:PSMA1007,PSMA-1007
CAS:2093321-19-6
一、Product parameters:
1.Molecular formula:C49H55FN8O16
2.Molecular weight:1031.0174
3.Packaging specification:1g、5g、10g, flexible packaging, including 100mg packaging and 500mg 1g and 5g large packaging
Product structure:
二、Reaction characteristics:
PSMA1007是一种特异性膜抗原PSMA抑制剂,通过与PSMA结合,能够抑制其介导的生物学功能。PSMA是一种FBP酶,具有良好的亲和力和特异性。其通过与PSMA的胞内域结合,抑制其介导的生物学功能。
PSMA1007是由两种主要单体构成的聚合物,一种是苯乙烯,另一种是丙烯酸。通过控制这两种单体的比例和聚合条件,可以获得具有不同性质和应用的PSMA1007聚合物。
在过去的几十年中,PSMA1007一直是化学研究的重要领域。作为一种高分子化合物,它具有独特的物理和化学性质,其应用也广泛存在于医药、材料科学和工程领域。然而,对于PSMA1007的具体合成方法及其应用仍需进一步探索和研究。
(上述信息均由陕西新研博美生物科技有限公司的小编木木所整理)
三、Matters for use:
It is sensitive to light and temperature. In order to use the reagent effectively, the material should always be kept in a low temperature dry condition, away from light, and avoid frequent thawing and freezing.
四、storage conditions:
Store at - 20 ℃ as much as possible. If conditions permit, the material can be treated under inert gas to obtain better stability of the reagent.
【Reagent related products】
Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro)
DOTA-cyclo(RGDfK) acetate
FAP-2286
Cyclo(-D-Ala-Val)
Cyclo(Hpro-Leu)
Cyclo(D-Trp-Tyr)
Nodaga-theranost 1393933-89-5
DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 250612-06-7
NOTA-E(cRGDfK)2
Cyclo(D-Ala-Pro)
FAPI-4-NH2
Cyclo(-Tyr-Hpro)
DOTAGA-DTyr(3I)-DPhe-DLys(Sub-Lys-urea-Glu),PSMA IandT
cyclo(RGDFK(DOTA))
DOTA-Cyclo(RGDfK) acetate
Cyclo(Arg-Gly-Asp-D-Tyr-Cys)
Cyclo(L-Pro-L-Tyr),Maculosin
DOTA-JR-11 1039726-31-2
Satoreotide 1801415-23-5
Cyclo-(D-Tyr-Gly)
Nodaga-rgd 1414595-49-5
(3-Azidobutyl)Cyclohexane
(Azidomethyl)-Cyclohexane
DOTA-E-[cyclo(RGDfK(Acp))]2
(R)-tert-Bu4-DOTAGA